Cost Parameters for a Chinese Stroke Treatment Economic Model

5.5 KB of cost parameters used in a Markov cohort model evaluating percutaneous PFO closure versus medical therapy for cryptogenic stroke in China. The dataset, authored by Chen Chen and updated in March 2026, supports an economic analysis from a Chinese healthcare payer perspective over a 30-year horizon. It likely contains cost data derived from multi-center hospital surveys in China.

Use Cases

• Replicating the cost-effectiveness analysis of PFO closure for cryptogenic stroke based on the described Markov model structure.
• Sensitivity analysis on economic model outcomes based on cost parameter ranges mentioned in the description.
• Informing resource allocation decisions for stroke prevention services based on the Chinese-specific cost data.
• Benchmarking healthcare costs for stroke treatment and recurrent events in a Chinese context.

Strengths

• Specific cost data sourced from multi-center hospital surveys in China.
• Parameters are tied to a clearly defined Markov model with four health states and a 30-year time horizon.
• Released under a permissive CC-BY-4.0 license for reuse.

Limitations

• The dataset is very small at 5.5 KB, indicating limited scope.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Chen Chen via figshare.

Collection Method

Cost data derived from multi-center hospital surveys in China; transition probabilities from the RESPECT trial extended follow-up data.

Time Range

Model horizon is 30 years.

Freshness

Last updated 2026-03 17:23:30; freshness should be verified.

Geography

China.